Finance

Lists
002252:SHE
Shanghai RAAS Blood Products Co Ltd
CNÂ¥4.76
-1.45%
(-0.070) 1D
Nov 12, 3:04:21 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 002252...
Open
CNÂ¥4.82
High
CNÂ¥4.85
Low
CNÂ¥4.75
Mkt. cap
32.24B
Avg. vol.
52.39M
Volume
38.41M
Dividend
1.01%
Quarterly dividend
CNÂ¥0.01
Ex-dividend date
Jun 24, 2026
P/E ratio
28.90
52-wk high
CNÂ¥6.95
52-wk low
CNÂ¥4.18
EPS
CNÂ¥0.16
Shares outstanding
6.59B
No. of employees
4K
Open
CNÂ¥4.82
High
CNÂ¥4.85
Low
CNÂ¥4.75
Mkt. cap
32.24B
Avg. vol.
52.39M
Volume
38.41M
Dividend
1.01%
Quarterly dividend
CNÂ¥0.01
Ex-dividend date
Jun 24, 2026
P/E ratio
28.90
52-wk high
CNÂ¥6.95
52-wk low
CNÂ¥4.18
EPS
CNÂ¥0.16
Shares outstanding
6.59B
No. of employees
4K
News stories
From web sources and news partners
About Shanghai RAAS Blood Products Co Ltd
CEO-
Employees4.04K
FoundedOct 29, 1988
Headquarters-
SectorHealth Care
IndustryBiotechnology
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
1.26B
1.51B
1.70B
1.73B
Cost of goods sold
828.13M
942.79M
1.15B
1.09B
Cost of revenue
828.13M
942.79M
1.15B
1.09B
Research and development expenses
73.79M
44.42M
89.74M
73.43M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
241.85M
182.57M
196.48M
225.08M
Operating expense
308.55M
241.16M
306.95M
312.75M
Total operating expenses
1.14B
1.18B
1.45B
1.40B
Operating income
120.45M
325.54M
246.49M
330.24M
Other non operating income
-21.93M
917.46K
10.30M
4.20M
EBT including unusual items
181.81M
375.95M
425.90M
367.38M
EBT excluding unusual items
191.26M
381.36M
418.35M
391.97M
Income tax expense
75.53M
60.12M
80.51M
49.67M
Effective tax rate
41.55%
15.99%
18.90%
13.52%
Other operating expenses
16.06M
13.04M
12.14M
13.79M
Net income
106.27M
315.83M
345.39M
317.70M
Net profit margin
8.45%
20.92%
20.32%
18.31%
Earnings per share
0.02
-
-
-
Interest and investment income
96.72M
9.88M
239.80M
84.97M
Interest expense
-20.78M
-20.81M
-20.03M
-19.81M
Net interest expenses
75.95M
-10.93M
219.77M
65.15M
Depreciation and amortization charges
-
-
-
-
EBITDA
175.88M
380.96M
309.55M
385.67M
Gain or loss from assets sale
-21.16M
-
-2.18M
2.18M
Upcoming events
AI content may include mistakes. Learn more
Google apps